Sheryl
LaCoursiere, PhD, RN-BC
Cynthia
Patton, RN, MSN
HYPERTENSION
Blood flowing through blood vessels
HYPERTENSION PRESENTATION
Hypertension.ppt - Hypertension powerpoint presentation- has clickable links to web sites
HypertensionColor.pdf - Presentation slides in color
HypertensionBW.pdf- Presentation slides in black & white
Hypertension.doc- Speaker's notes for pathophysiology section of the presentation
JNC GUIDELINES
On the JNC home page, there are a number of important resources for clinicians as well as patient resources, including:
JNC 7 Reference Card (2 pages)- A great summary of Evaluation, Treatment,
JNC 7 Guidelines Electronic Version- for Palm or Pocket PC devices
EVALUATION OF HYPERTENSION
Hypertension is evaluated by a four-step process:
1. Blood pressure is classified
2. A diagnostic workup is performed
The patient is then assessed for:
3. Major cardiovascular disease (CVD) risk factors; and
4. Identifiable causes of hypertension
Evaluation of Hypertension
From the JNC Reference Card
TREATMENT OF HYPERTENSION
Treatment begins with a patient who has a blood pressure of greater than 140/90, and in patients with diabetes or renal failure, greater than 130/80. The clinician then follows the algorithm based on the patient's stage of hypertension.
Treatment of Hypertension
From the JNC Reference Card
LIFESTYLE MODIFICATIONS, and the DIETARY APPROACHES TO STOP HYPERTENSION (DASH) DIET
Lifestyle modifications are the first line of treatment in hypertension. According to the JNC, lifestyle modifications can reduce systolic blood pressure from a low of 2-8 mm Hg for dietary sodium restriction, to a high of 5-20 mm Hg for weight reduction.
Lifestyle Modification Recommendations
From the JNC Reference Card
DASH Eating Plan (56 pages)- The DASH eating plan has sodium reduction at the core of its recommendations
MEDICATIONS
If the patient does not respond to lifestyle modification, medications are initiated (refer to the treatment diagram above).
Various classes of medications are used, including
Thiazide Diuretics (THIAZ)
Beta-blockers (BB)
Angiotensin Converting Enzyme Inhibitors (ACEI)
Angiotensin Release Blockers (ARB)
Aldosterone antagonists (ALDO ANT)
Calcium Channel blockers (CCB)
Examples of medications for each class are shown below
Oral Antihypertensive Medications
From the JNC Complete Report, pp. 27-28
The JNC has specific guidelines for patients with certain conditions and risk factors, termed Compelling Indications, including:
Heart failure
Post myocardial infarction
High cardiovascular disease (CVD) risk
Diabetes
Chronic kidney disease; and
Recurrent stroke prevention
Compelling Indications for Individual Drug Classes
From the JNC Reference Card
This diagram illustrates the mechanism of action of two important hypertension medications, the Angiotensin Converting Enzyme (ACE) Inhibitors, and Angiotensin Release Blockers (ARBs).
The majority of patients will require two medications to reach their blood pressure goal!
Modified April 18, 2007
Questions?